NextCure to Terminate CMO Udayan Guha Effective October 31
NextCure said it will terminate Chief Medical Officer Udayan Guha’s employment effective October 31, 2026, in contemplation of its pending merger with Avere Therapeutics.
NextCure said it will terminate Chief Medical Officer Udayan Guha’s employment effective October 31, 2026, in contemplation of its pending merger with Avere Therapeutics.